Results 111 to 120 of about 273,161 (350)

Non-Hogkins lymphoma ′masquerading′ as pott′s disease in a 13-year old boy: A case report

Sahel Medical Journal, 2010
Lymphomas are malignant neoplasms of the lymphoid lineage which are broadly classified as either Hodgkin disease or as non-Hodgkin lymphoma (NHL).
O A Adegboye
doaj  

Primary Dural Lymphoma: Clinical Cases and Literature Review

Case Reports in Medicine, 2020
Primary dural lymphoma (PDL) is an extranodal non-Hodgkin lymphoma that accounts for less than 1% of all central nervous system lymphomas. Primary dural lymphoma grows from the dura mater, and it is often diagnosed as meningioma or acute subdural ...
M. Dobran, R. Paracino, F. Mancini, D. Nasi   +3 more
doaj   +1 more source

Emerging targets in human lymphoma: targeting the MYD88 mutation [PDF]

, 2016
B cell neoplasms co-opt the molecular machinery of normal B cells for their survival. Technological advances in cancer genomics has significantly contributed to uncovering the root cause of aggressive lymphomas, revealing a previously unknown link ...
Horikawa, Keisuke, Jeelall, Yogesh S., Wang, James Q.   +2 more
core   +1 more source

Diagnosing Non-Hodgkin's Lymphoma [PDF]

Laboratory Medicine, 2007
Non-Hodgkin’s lymphomas (NHLs) are lymphoid malignancies representing the sixth most common type of cancer diagnosed in men and women in the United States. Between 1973 and 2000, incidence rates for NHL in the United States increased nearly 80%, one of the largest increases observed among all cancers. 1 An increased risk of disease has been found among
openaire   +1 more source

Population pharmacokinetics and dose–response relationships of mitoxantrone in children with acute myeloid leukaemia

British Journal of Clinical Pharmacology, EarlyView.
Background Information on mitoxantrone pharmacokinetics in children is lacking and reduced dosing regimens applied to infants are supported by limited scientific rationale. The current study characterized mitoxantrone pharmacokinetics in a childhood acute myeloid leukaemia patient population and provides a data‐informed assessment of dosing.
Andrew M. Brandon, Hinke Huisman‐Siebinga, Shelby Barnett, Paul Wetherell, Pamela Kearns, Brenda Gibson, Nicholas Heaney, Owen Smith, André Baruchel, Arnaud Petit, Andrew Moore, Kayode Ogungbenro, Alwin D. R. Huitema, Gareth J. Veal   +13 more
wiley   +1 more source

Immune Thrombocytopenia in a Child with T Cell Lymphoblastic Lymphoma

Case Reports in Hematology, 2016
We describe the case of a 13-year-old boy who presented with persistent thrombocytopenia during maintenance chemotherapy with mercaptopurine and methotrexate for T cell lymphoblastic lymphoma.
Kayo Tokeji, Sachi Sakaguchi, Tomoko Kurimoto, Junya Fujimura, Toshiaki Shimizu   +4 more
doaj   +1 more source

LARGE EXTRANODAL NON HODGKIN'S LYMPHOMA OF THE PARAPHARYNGEAL SPACE [PDF]

, 2013
Of all head and neck tumors, 0.5% to 0.8% of them are localized in the parapharyngeal space. Non-Hodgkin’s lymphomas in this site are extremely rare. There are described in literature as either isolated cases or small series of tumors of that space.
Aleric, Zorica, Bauer, Vladimir
core   +1 more source

Immunosenescence and lymphomagenesis [PDF]

, 2018
One of the most important determinants of aging-related changes is a complex biological process emerged recently and called \u201cimmunosenescence\u201d.
A Beheshti, A Engert, A Grignolio, A Nicolae, A Rosenwald, A Tucci, AM Evens, BB Hart, BF Skinnider, BK Edwards, BO Nilsson, C Caruso, C Castelo-Branco, C Falandry, C Falandry, C Franceschi, C Franceschi, C Kenis, C Sarkozy, C Sarkozy, C Thieblemont, CC Porter, CM Koebel, D Aldinucci, D Hanahan, D Zhou, DB Palmer, DM Parkin, DP Shanley, E Campo, E Cesarman, E Zucca, F Suarez, FL Erdkamp, FT Hakim, G Accardi, G Genovese, G Lenz, G Pawelec, GM Clifford, H Wildiers, I Schwering, J Campisi, J Wang, JJ Castillo, L Malaguarnera, LM Morton, M Goto, M Martelli, M Weltevrede, Marco Santoro, Mariasanta Napolitano, Melania Carlisi, N Asano, NS Wong, O Balague Ponz, P Skrabek, PJ Linton, PR Taylor, PR Walker, R Kim, RF Jarrett, RL Bowman, RR Montgomery, S Dubois, S Joos, S Mareschal, S Mathas, S Mathas, S Puvvada, Salvatrice Mancuso, Sergio Siragusa, SH Swerdlow, Simona Raso, SJ Morrison, SJ Proctor, SL Glaser, SR Gordon, SR Hadrup, T Finkel, T Fulop, T Fulop, T Fülöp, T Fülöp, T Fülöp, T Ishida, T Wada, W Drew, W Klapper, Z Ju, Z Song   +90 more
core   +1 more source

Non-Hodgkin Lymphoma and Occupational Exposure to Agricultural Pesticide Chemical Groups and Active Ingredients: A Systematic Review and Meta-Analysis

International Journal of Environmental Research and Public Health, 2014
This paper describes results from a systematic review and a series of meta-analyses of nearly three decades worth of epidemiologic research on the relationship between non-Hodgkin lymphoma (NHL) and occupational exposure to agricultural pesticide active ...
Leah H. Schinasi, M. Leon
semanticscholar   +1 more source

Assessing Overall Survival Benefits in Advanced Cancers: The Role of External Comparator Cohort Studies with Real‐World Data

Clinical Pharmacology &Therapeutics, EarlyView.
External comparator cohort (ECC) studies with real‐world data (RWD) may provide more reliable estimates of treatment differences compared to single‐arm trials (SAT), yet they face limitations such as selection bias and data heterogeneity. This study assessed the perceived strength of evidence of ECC studies compared to SAT and randomized controlled ...
Francesco Pignatti, Tarec Christoffer El‐Galaly, Martin Kaiser, Kimmo Porkka, Robin Doeswijk, Peter Mol, Donna R. Rivera, Catherine C. Lerro, Ulrich‐Peter Rohr, Patrice Verpillat, Antonios Valachis, Dario Trapani, Massimo Di Maio, Nicola Latino, Raul Cordoba, Nathan Cherny, Miriam Koopman, Diogo Martins‐Branco, George Pentheroudakis, Douwe Postmus   +19 more
wiley   +1 more source